RxDoctor Payments Data

Jamie Hall, MD

Family Medicine · Detroit, MINPI 1912910696

Payments from drug & device makers

$1,420in general payments, 2019–2025

Across 21 payments — averaging $67.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mentor Worldwide LLC$284
  • Integra Lifesciences Corporation$257
  • Pfizer$181
  • AbbVie$145
  • Lilly USA, LLC$125
  • Sientra, Inc.$121
  • plus $307 from 6 others

What the payments were for

  • Food & beverage$1,420100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,420 in reported general payments places this provider in the 75th percentile of 3,945 family medicine providers in Michigan.

See all family medicine providers in Michigan

Medicare billing

Part B allowed, 2024
$38,254
Medicare patients
69
Services billed
2,298

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin257$291,277
TrulicityDulaglutide104$93,513
JanumetSitagliptin Phos/Metformin Hcl70$64,664
OzempicSemaglutide50$45,826
EliquisApixaban54$45,027
EntrestoSacubitril/Valsartan14$23,778
Combivent RespimatIpratropium/Albuterol Sulfate39$18,265
Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl93$15,658
FarxigaDapagliflozin Propanediol17$13,428
Albuterol Sulfate HfaAlbuterol Sulfate356$12,846
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog32$12,072
JanuviaSitagliptin Phosphate26$11,046
SymbicortBudesonide/Formoterol Fumarate46$11,033
BrilintaTicagrelor17$10,606
Lantus SolostarInsulin Glargine,hum.Rec.Anlog103$9,723

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$125$93,513104 claims
MerckJanumet, Januvia$120$75,71096 claims
PfizerEliquis$181$45,02754 claims
AstraZenecaFarxiga, Symbicort, Brilinta$112$35,06780 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,945 family medicine providers in Michigan.

Other family medicine in Detroit

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →